Scientific Program - Retina

Please see below the COPHy Scientific Program. Please click on the appropriate section to view the relevant program. Please note that the program is subject to change. To view the program timetable / overview, please click here

Anterior Segment Glaucoma Other
Chairs: Neil Bressler, USA and Anat Loewenstein, Israel
08:30-08:40 Welcome to COPHy EU 2019: Neil Bressler, USA
08:40-08:50 Opening Remarks: Paul Coulson, Chairman and CEO, Ardagh Group
EU 2019 Recipients of Global Ophthalmology Awards Program
Moderator: Francesco Bandello, Italy
(*GOAP is awarded by an independent committee of eminent ophthalmology professionals – consistent with COPHy priorities to support research and education of young ophthalmologists, European awardees of GOAP awards are presented at annual COPHy meetings, with poster presentations of awardees.)
Big Controversies in Ophthalmology in 2019
Chairs: Neil Bressler, USA and Francesca Cordeiro, UK
09:00-09:30 Debate I: Proliferative Diabetic Retinopathy: Anti VEGF without PRP is an Acceptable First Step
09:00-09:10 Yes: Sobha Silvaprasad, UK
09:10-09:20 No: Clare Bailey, USA
09:20-09:30 Discussion
09:30-10:00 Debate II: Port Delivery Systems are the Next Step in Anti-VEGF Treatment
09:30-09:40 Yes: Eugene de Juan, USA
09:40-09:50 No: William Mieler, USA
09:50-10:00 Discussion
10:00-10:30 Debate III: Artificial Intelligence (AI) and Deep Learning will soon have a Role in Glaucoma
10:00-10:10 Yes: Colin Willoughby, UK
10:10-10:20 No: Francesca Cordeiro, UK
10:20-10:30 Discussion
10:30-11:00 Visit Exhibits & Coffee Break
RETINA I | Neovascular (‘Wet”) AMD Management
Chairs: Winifried Amoaku, UK and Patricia Quinlan, Ireland and James Talks, UK
11:00-11:30 Debate I: Brolucizumab Represents an Incremental Improvement over Aflibercept
11:00-11:10 Yes: Francesco Bandello, Italy
11:10-11:20 No: Stela Vujosevic, Italy
11:20-11:30 Discussion
11:30-12:00 Debate II: Typically Prefer Treat and Extend Regimens to PRN Regiemens for Neovascular AMD
11:30-11:40 Yes: James Talks, UK
11:40-11:50 No: Susan Bressler, USA
11:50-12:00 Discussion
12:00-12:30 Debate III: Treatment of Non-exudative CNV should begin when Detected on OCT Angiography
Yes: Paolo Lanzetta, Italy
12:10-12:20 No: Patricia Udaondo, Spain
12:20-12:30 Discussion
12:30-12:50 Visit Exhibits & Technical Break
12:50-13:00 Lunch Box Pick-Up
13:00-14:00 Industry-Sponsored Luncheon Symposium
14:00-14:30 Visit Exhibits & Desert Break
14:30-15:30 Industry-Sponsored Symposium
15:30-17:00 RETINA II | Diabetic Macular Edema (DME)
Chairs: Clare Baliey, UK and Susan Bressler, USA and Paolo Lanzetta, Israel
15:30-16:00 Debate I: Corticosteroids are Crucial in the Management of Chronic DME
15:30-15:40 Yes: Barry Kuppermann, USA
15:40-15:50 No: Susan Bressler, USA
15:50-16:00 Discussion
16:00-16:30 Debate II: Three-Month Response Typically Predicts 2-Year Outcomes
16:00-16:10 Yes: Patricia Udaondo, Spain
16:10-16:20 No: Neil Bressler, USA
16:20-16:30 Discussion
16:30-17:00 Debate III: Ang2-inhibition offers long-term sustained treatment benefits for DME
16:30-16:40 Yes: Michael Larsen, Denmark
16:40-16:50 No: Patricia Udaondo, Spain
16:50-17:00 Discussion


Saturday APRIL 6, 2018
07:45-09:00 Vision Academy in Retina 2019
Chairs: Neil Bressler, USA and Anat Loewenstein, Israel
07:45-07:55 An introduction to the Vision Academy: Neil Bressler, USA
07:55-08:10 An overview of posters presented at COPHY EU from the European 2019 recipients of the Global Ophthalmology Awards Program (GOAP): David Keegan, Ireland
08:10-08:30 Debate I: The fellow eye of a patient who has CNV being treated in the first eye should be monitored using sophisticated home monitoring technology
08:10-08:15 For: Anat Loewenstein, Israel
08:15-08:20 Against: Paolo Lanzetta, Italy
08:20-08:25 Presentation of viewpoint: Neil Bressler, USA
08:25-08:30 Questions
08:30-08:50 Debate II: Treatment of Diabetic Retinopathy Needs to Take into Account Other Systemic Complications of Diabetes
08:30-08:35 Yes: Richard Gale, UK
08:35-08:40 No: Sobha Sivaprasad, UK
08:40-08:45 Presentation of viewpoint: Anat Loewenstein, Israel
08:45-08:50 Questions
08:50-09:00 Looking forward with the Vision Academy: Anat Loewenstein, Israel
09:00-10:30 RETINA III | Surgical Retina and Trauma
Chairs: William Mieler, USA and Joseph Moisseiev, Israel and : Stratos Gotzaridis, Greece
09:00-09:30 Debate I: Vitreo-Macular Ttraction Typically should be Managed by Vitrectomy rather than Pneumatic Vitreolysis or Ocriplasmin
09:00-09:10 Yes: Stratos Gotzaridis, Greece
09:10-09:20 No: William Mieler, USA
09:20-09:30 Discussion
09:30-10:00 Debate II: Total Retinal Ddetachment with 1 hour Equatorial Tear at 5 o'clock, Phakic Eye, 40 Years Old: Vitrectomy, not Scleral Buckle
09:30-09:40 Yes: Stratos Gotzaridis, Greece
09:40-09:50 No: Joseph Moisseiev, Israel
09:50-10:00 Discussion
10:00-10:30 Debate III: Heads-Up Displays are Ready for Prime Time
10:00-10:10 Yes: Joseph Moisseiev, Israel
10:10-10:20 No: Francesco Boscia, Italy
10:20-10:30 Discussion
10:30-11:00 Visit Exhibits & Coffee Break
RETINA IV | Non-neovascular ("Dry") Age-related Macular Degeneration and Hereditary Retinal Diseases
Chairs: Hendrik Scholl, Switzerland and Jayakrishna Ambati, USA
11:00-11:30 Debate I: Complement Inhibition Remains a Promising Strategy for Geographic Atrophy
11:00-11:10 Yes: Richard Gale, UK
11:10-11:20 No: Usha Chakravarthy, UK
11:20-11:30 Discussion
11:30-12:00 Debate II: Gene Therapy for Hereditary Retinal Diseases are Game Changers
11:30-11:40 Yes: Hendrik Scholl, Switzerland
11:40-11:50 No: Usha Chakravarthy, UK
11:50-12:00 Discussion
12:00-12:30 Debate III: AI with Deep Learning Programs Should be Used to Screen/Monitor AMD
12:00-12:10 Yes: Jayakrishna Ambati, USA
12:10-12:20 No: Tunde Peto, UK
12:20-12:30 Discussion
12:30-12:50 Visit Exhibits & Technical Break
12:50-13:00 Lunch Box Pick-Up
Industry-Sponsored Luncheon Symposium
14:00-14:30 Visit Exhibits & Dessert Break
RETINA V | Imaging Controversies
Chairs: Usha Chakravarthy, UK and Hendrik Scholl, Switzerland and Winifried Amoaku, UK
14:30-15:00 Debate I: OCT Angiography Should be Used to Follow Treatment of Neovascular AMD
14:30-14:40 Yes: Paolo Lanzetta, Italy
14:40-14:50 No: Tunde Peto, UK
14:50-15:00 Discussion
15:00-15:30 Debate II: 3D Displays are a Surgical Advance
15:00-15:10 Yes: Francesco Boscia, Italy
15:10-15:20 No: William Mieler, USA
15:20-15:30 Discussion
15:30-16:00 Debate III: Autofluorescence Imaging should be used to Monitor Geographic Atrophy
15:30-15:40 Yes: Hendrik Scholl, Switzerland
15:40-15:50 No: James Talks, UK
15:50-16:00 Discussion
16:00-17:30 THINK TANK: Rapid Cases across Ophthtalmology
Chairs: Barry Kuppermann, USA and Tunde Peto, UK
16:00-16:30 Debate I: Five years after initial presentation you are pleased you choose anti-VEGF over PRP for PDR:
16:00-16:10 Yes: Sobha Sivaprsad, Italy
16:10-16:20 No: Michael Larsen, Denmark
16:20-16:30 Discussion
16:30-17:00 Debate II: Ultra-Wide-field retinal photography is essential to managing diabetic retinopathy
16:30-16:40 Yes: Richard Gale, UK
16:40-16:50 No: Stela Vujosevic, Italy
16:50-17:00 Discussion
17:00-17:30 Debate II: Do we need to examine patients if imaging is performed?
17:00-17:10 Yes: Patricia Quinlan, Ireland
No: Barry Kuppermann, USA
17:20-17:30 Discussion